Is Lam Research (LRCX) a risky stock?
As of July 27, 2026, Clavix grades Lam Research (LRCX) C- for risk, a composite score of 54 out of 100 on an A+ to F scale, which puts LRCX in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
LRCX price, last 3 months
LRCX's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind LRCX's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how LRCX scores on each, as of July 27, 2026.
What's moving LRCX's risk right now
Company-specific signals Clavix flags behind LRCX's current grade, drawn from recent news and filings as of July 27, 2026.
Lam is collaborating with imec, KU Leuven, and Samsung on next-generation 3D-DRAM using an oxide-semiconductor architecture, keeping it positioned for future advanced memory equipment orders.
Substrate supplier AXT is expected to lack the ingredients for an earnings beat in its upcoming report. The evidence doesn't spell out a direct impact on Lam rating.
Recent LRCX news
The latest headlines Clavix ingested for Lam Research, newest first. These feed the news-sentiment dimension of LRCX's grade.
What a C- grade means
On the Clavix A+ to F scale, LRCX's composite of 54 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell LRCX or any security. Grades are risk indicators, not predictions of return. Data may be delayed.